Uganda Cancer Institute

Running trials

• Not yet recruiting

  KeyScope Study in Uganda

  NCT06212570· Duke University· Source

• Not yet recruiting

  Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

  NCT07576725· Phase 2· Fred Hutchinson Cancer Center· Source

• Recruiting

  A Study of Propranolol to Treat Kaposi Sarcoma

  NCT05797662· Phase 2· AIDS Malignancy Consortium· Source

• Recruiting

  Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

  NCT07276360· Phase 2· Uganda Cancer Institute· Source

• Active, not recruiting

  A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)

  NCT05904886· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

  NCT05894239· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa

  NCT04704648· AIDS Malignancy Consortium· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

  NCT05296798· Phase 3· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Cervical cancer2 recruiting
• Childhood cancers2 recruiting
• Sarcoma2 recruiting
• Bladder cancer1 recruiting
• Colorectal cancer1 recruiting
• Head and neck cancer1 recruiting
• HIV1 recruiting
• Hodgkin lymphoma1 recruiting
• Kidney cancer1 recruiting
• Lung cancer1 recruiting
• Melanoma1 recruiting

Closed trials

• Completed

  Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection

  NCT03601806· Phase 2· AIDS Malignancy Consortium· Source

• Completed

  HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV

  NCT03284866· Phase 3· AIDS Malignancy Consortium· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Cervical cancer25 works · 2 trials